{"name":"D3 Bio (Wuxi) Co., Ltd","slug":"d3-bio-wuxi-co-ltd","ticker":"","exchange":"","domain":"d3biowuxi.com","description":"D3 Bio (Wuxi) Co., Ltd is a biotechnology company focused on the development of innovative therapies. The company currently has three drug candidates in Phase 1 clinical trials, targeting various therapeutic areas.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNaU01NV9VZlV2VWZKNThwem4xN3BTSkhSS1BzZjZTc3BmeWFVTVNmeWk3U0cwYzRLRGVGaVdJcFpBWTNvX2JkcXVyUE9vUVhHczhqX21ZWGphbzNQSUFkZHVYcTlhZVNBNFREYnFHMjNCdER4OTJXdkZQZWZZajg4SnJVc3Vpazh1QjZtTzlETFQycGNlR3M0d0l4MlczQ0ZtZDZV?oc=5","date":"2025-12-10","type":"trial","source":"BioWorld News","summary":"D3 Bio raises $108M series B to move KRAS G12C into phase III - BioWorld News","headline":"D3 Bio raises $108M series B to move KRAS G12C into phase III","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNOXkyMVBJUjRFZXk5UFRrV3dkaDIxNDFLLURpMTZlTkdRYjVDQ3dISkt2ZU9vSm14MHhJSGFFSlNsSXk4VmZkMFRKc25IQXppdVVHV0Y5R0t1bXh0dlZSb0VScE1lSnMyVThFZlJzdVFxSl9QU3lFUjI4WlZXbzcwSTNza25ZZWlFX2c?oc=5","date":"2025-12-10","type":"pipeline","source":"Axios","summary":"D3 Bio's $108m, Blackstone's electricity bet, and Nick Clegg's move - Axios","headline":"D3 Bio's $108m, Blackstone's electricity bet, and Nick Clegg's move","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOVG53ZWZTeVp1NF9BQ3g1LXp1Z19vNDkxYTFvU1lDZEtqbnk1TWVRaEFRUVBFaHRpUHpRSklWUU9pVm04bkxQU1NvR1Z4V2w0MW13dG4yNTZfMUdNaXhPa2FLLTJDZ2xnYW5uMFBfdTM0WVRJM1U0VXZQc3YweFprMUFzMEJYSWFCN1FqeU5oN29DTXlwNnU4WUEwcXZHSGQyU1dLcGVkbzdIRV9BajZn?oc=5","date":"2024-05-30","type":"pipeline","source":"BioWorld News","summary":"Next-generation KRAS G12C inhibitor shows relevant antitumor activity - BioWorld News","headline":"Next-generation KRAS G12C inhibitor shows relevant antitumor activity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxObWJBeldCLWgwVkhzYU5PbGNrZzJrY2FzcnNrcnBSdmlOLVJ0aHVPWmoySGxoWDhwaXhUMmFxcnNDWmNvaEpVTEZGMzVFdXRhRXpnT3hOOTlQclZ6bm9WcU40cUZWeVhfeVVNQ0pYQ0xQanY1Nkw3cWVTYzlRN0xnX0ZoUmlUWk1fMU92UjNtdlN6QW1IWl9qS2FPU2M?oc=5","date":"2024-04-08","type":"pipeline","source":"BioSpace","summary":"D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline - BioSpace","headline":"D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}